Published in J Acquir Immune Defic Syndr on August 15, 2012
Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for program quality improvement and community engagement. PLoS One (2014) 0.90
Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort. AIDS Res Ther (2014) 0.85
Predicting Hospitalised Paediatric Pneumonia Mortality Risk: An External Validation of RISC and mRISC, and Local Tool Development (RISC-Malawi) from Malawi. PLoS One (2016) 0.75
The Incremental Value of Repeated Induced Sputum and Gastric Aspirate Samples for the Diagnosis of Pulmonary Tuberculosis in Young Children With Acute Community-Acquired Pneumonia. Clin Infect Dis (2017) 0.75
Hospital admissions from a pediatric HIV care and treatment program in Malawi. BMC Pediatr (2016) 0.75
Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med (2008) 17.12
Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet (2011) 14.16
Countdown to 2015 decade report (2000-10): taking stock of maternal, newborn, and child survival. Lancet (2010) 12.15
A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med (2003) 7.39
Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration. S Afr Med J (2009) 2.97
The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin Infect Dis (2005) 2.81
Every death counts: use of mortality audit data for decision making to save the lives of mothers, babies, and children in South Africa. Lancet (2008) 2.43
Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol (2011) 2.41
Emergence of a peak in early infant mortality due to HIV/AIDS in South Africa. AIDS (2009) 1.86
Paediatric hospital admissions at a South African urban regional hospital: the impact of HIV, 1992-1997. Ann Trop Paediatr (1999) 1.84
Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy. AIDS (2009) 1.51
Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy. BMC Pediatr (2008) 1.49
Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa. Bull World Health Organ (2006) 1.41
Temporal trends in baseline characteristics and treatment outcomes of children starting antiretroviral treatment: an analysis in four provinces in South Africa, 2004-2009. J Acquir Immune Defic Syndr (2011) 1.33
Antiretroviral therapy responses among children attending a large public clinic in Soweto, South Africa. Pediatr Infect Dis J (2011) 1.30
Conversations with mothers: exploring reasons for prevention of mother-to-child transmission (PMTCT) failures in the era of programmatic scale-up in Soweto, South Africa. AIDS Behav (2012) 1.26
High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study. BMC Infect Dis (2011) 1.24
The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis. AIDS (2011) 1.19
Treating HIV-infected mothers reduces under 5 years of age mortality rates to levels seen in children of HIV-uninfected mothers in rural South Africa. Antivir Ther (2012) 1.13
Pediatric admissions with human immunodeficiency virus infection at a regional hospital in Soweto, South Africa. J Trop Pediatr (2000) 1.03
HIV infection and in-hospital mortality at an academic hospital in South Africa. Arch Dis Child (2000) 1.02
Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa. Pediatr Infect Dis J (2011) 0.87
Vertically transmitted HIV-1 infection in children. A report of 23 cases. S Afr Med J (1991) 0.78
A systematic review of task- shifting for HIV treatment and care in Africa. Hum Resour Health (2010) 6.48
Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA (2005) 5.12
'Doing' health policy analysis: methodological and conceptual reflections and challenges. Health Policy Plan (2008) 4.81
Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet (2008) 4.70
Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study. PLoS One (2009) 3.66
Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis (2005) 3.50
Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter? J Urol (2012) 3.30
Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. Science (2008) 3.17
Women in couples antenatal HIV counseling and testing are not more likely to report adverse social events. AIDS (2005) 3.15
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS (2007) 3.04
Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy. Clin Infect Dis (2009) 2.75
Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial. JAMA (2010) 2.67
Improving the recruitment activity of clinicians in randomised controlled trials: a systematic review. BMJ Open (2012) 2.50
Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms. Lancet Infect Dis (2005) 2.42
The politics of AIDS in South Africa: beyond the controversies. BMJ (2003) 2.38
Issues in the design of a clinical trial with a behavioral intervention--the Zambia exclusive breast-feeding study. Control Clin Trials (2004) 2.36
Alterations in xenobiotic metabolism in the long-lived Little mice. Aging Cell (2007) 2.35
Global surveillance of emerging Influenza virus genotypes by mass spectrometry. PLoS One (2007) 2.29
Distinguishing the temporal association between women's intravaginal practices and risk of human immunodeficiency virus infection: a prospective study of South African women. Am J Epidemiol (2006) 2.28
Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission. AIDS (2006) 2.23
Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. AIDS (2012) 2.15
Trust and health worker performance: exploring a conceptual framework using South African evidence. Soc Sci Med (2005) 2.11
Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer (2002) 2.10
Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis. J Infect Dis (2010) 2.09
Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts. J Infect Dis (2006) 2.05
Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol (2006) 2.04
Correlates of self-rated successful aging among community-dwelling older adults. Am J Geriatr Psychiatry (2006) 1.99
CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ (2011) 1.96
Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl. AIDS (2006) 1.92
Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children. AIDS (2003) 1.88
Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy. Arch Dis Child (2012) 1.73
Growth faltering due to breastfeeding cessation in uninfected children born to HIV-infected mothers in Zambia. Am J Clin Nutr (2009) 1.73
Predictors of nonadherence to single-dose nevirapine therapy for the prevention of mother-to-child HIV transmission. J Acquir Immune Defic Syndr (2006) 1.71
Research gaps in protecting healthcare workers from SARS and other respiratory pathogens: an interdisciplinary, multi-stakeholder, evidence-based approach. J Occup Environ Med (2005) 1.70
Applying a framework for assessing the health system challenges to scaling up mHealth in South Africa. BMC Med Inform Decis Mak (2012) 1.57
Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy. AIDS (2009) 1.51
Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr (2008) 1.51
Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. J Natl Cancer Inst (2010) 1.50
Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance. Brain (2014) 1.49
Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol (2004) 1.46
HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea. Clin Infect Dis (2012) 1.45
Bartonella bacilliformis: a systematic review of the literature to guide the research agenda for elimination. PLoS Negl Trop Dis (2012) 1.44
A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility. Int J Drug Policy (2007) 1.43
HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine. AIDS (2011) 1.41
Commentary: Managing scaling up: what are the key issues? Health Policy Plan (2010) 1.41
Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr (2010) 1.38
Clean water helps but is not enough: challenges for safe replacement feeding of infants exposed to HIV. J Infect Dis (2009) 1.38
Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models. Sex Transm Infect (2012) 1.37
Development and pilot testing of a new psychosocial intervention for older Latinos with chronic psychosis. Schizophr Bull (2005) 1.31
Antiretroviral therapy responses among children attending a large public clinic in Soweto, South Africa. Pediatr Infect Dis J (2011) 1.30
Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study. BMC Public Health (2011) 1.30
Human resource development and antiretroviral treatment in Free State province, South Africa. Hum Resour Health (2008) 1.27
Early weaning increases diarrhea morbidity and mortality among uninfected children born to HIV-infected mothers in Zambia. J Infect Dis (2011) 1.26
Usefulness of multilocus polymerase chain reaction followed by electrospray ionization mass spectrometry to identify a diverse panel of bacterial isolates. Diagn Microbiol Infect Dis (2009) 1.25
Sexual behavior and HIV transmission risk of Ugandan adults taking antiretroviral therapy: 3 year follow-up. AIDS (2011) 1.25
Nested case-control study of cervical mucosal lesions, ectopy, and incident HIV infection among women in Cape Town, South Africa. Sex Transm Dis (2006) 1.25
Cutting Edge: Unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1. J Immunol (2009) 1.25
Protecting health care workers from SARS and other respiratory pathogens: a review of the infection control literature. Am J Infect Control (2005) 1.25
Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission. J Gen Virol (2006) 1.24
The transition to parenthood among young African American and Latino couples: relational predictors of risk for parental dysfunction. J Fam Psychol (2003) 1.24
An interactive web-based method of outreach to college students at risk for suicide. J Am Coll Health (2008) 1.23
Quality and equity of private sector care for sexually transmitted diseases in South Africa. Health Policy Plan (2002) 1.23
Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa. AIDS Res Hum Retroviruses (2011) 1.22
Scaling up health policies and services in low- and middle-income settings. BMC Health Serv Res (2010) 1.22
An integrated approach of community health worker support for HIV/AIDS and TB care in Angónia district, Mozambique. BMC Int Health Hum Rights (2009) 1.21
Preventing postnatal transmission of HIV-1 through breast-feeding: modifying infant feeding practices. J Acquir Immune Defic Syndr (2004) 1.21
Post-weaning breast milk HIV-1 viral load, blood prolactin levels and breast milk volume. AIDS (2006) 1.20
Highly enantioselective phenylacetylene additions to both aliphatic and aromatic aldehydes. Org Lett (2002) 1.20
Human immunodeficiency virus-specific CD8(+) T cells in human breast milk. J Virol (2002) 1.19
Intravaginal practices, HIV and other sexually transmitted diseases among South African women. Sex Transm Dis (2004) 1.18
Evolution of the PEBP gene family in plants: functional diversification in seed plant evolution. Plant Physiol (2011) 1.17
Effect of CD4+ T cell count and antiretroviral treatment on two serological HIV incidence assays. AIDS Res Hum Retroviruses (2011) 1.16
Otitis media, hearing loss, and language learning: controversies and current research. J Dev Behav Pediatr (2004) 1.15
In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a pharmaceutical research and manufacturers of america perspective. Drug Metab Dispos (2009) 1.15
Isoprene emission from terrestrial ecosystems in response to global change: minding the gap between models and observations. Philos Trans A Math Phys Eng Sci (2007) 1.15
Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission. PLoS One (2010) 1.13
When is a little knowledge dangerous? Circumstances of recent heroin overdose and links to knowledge of overdose risk factors. Drug Alcohol Depend (2006) 1.12
Poor early virologic performance and durability of abacavir-based first-line regimens for HIV-infected children. Pediatr Infect Dis J (2013) 1.12
Antiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatment. PLoS One (2011) 1.11
Induction therapy with protease-inhibitors modifies the effect of nevirapine resistance on virologic response to nevirapine-based HAART in children. Clin Infect Dis (2011) 1.10
Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women. J Acquir Immune Defic Syndr (2008) 1.10
Virologic response in children treated with abacavir-compared with stavudine-based antiretroviral treatment: a South African multi-cohort analysis. Pediatr Infect Dis J (2014) 1.09
Commissioning for rare diseases: view from the frontline. BMJ (2005) 1.09
Two-year follow-up of sexual behavior among HIV-uninfected household members of adults taking antiretroviral therapy in Uganda: no evidence of disinhibition. AIDS Behav (2008) 1.07
Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes. J Infect Dis (2013) 1.07
Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART. AIDS Res Ther (2006) 1.06
In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers. J Acquir Immune Defic Syndr (2006) 1.06
Genital herpes simplex virus infection and perinatal transmission of human immunodeficiency virus. Obstet Gynecol (2005) 1.06
A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression. J Acquir Immune Defic Syndr (2010) 1.05
Injection drug users' access to a supervised injection facility in Vancouver, Canada: the influence of operating policies and local drug culture. Qual Health Res (2011) 1.05
'It makes me want to run away to Saudi Arabia': management and implementation challenges for public financing reforms from a maternity ward perspective. Health Policy Plan (2004) 1.05
Bilateral adrenal haemorrhage presenting as epigastric and back pain. JRSM Short Rep (2012) 1.05
A new face for private providers in developing countries: what implications for public health? Bull World Health Organ (2003) 1.05
Community mapping and respondent-driven sampling of gay and bisexual men's communities in Vancouver, Canada. Cult Health Sex (2014) 1.05
Pregnancy loss and role of infant HIV status on perinatal mortality among HIV-infected women. BMC Pediatr (2012) 1.04
Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women. J Infect Dis (2011) 1.04
High concentrations of interleukin 15 in breast milk are associated with protection against postnatal HIV transmission. J Infect Dis (2009) 1.04
Associations of chemokine receptor polymorphisms With HIV-1 mother-to-child transmission in sub-Saharan Africa: possible modulation of genetic effects by antiretrovirals. J Acquir Immune Defic Syndr (2008) 1.04
Mobility in Hurler syndrome. J Pediatr Orthop (2008) 1.04
Simulating colonial growth of fungi with the Neighbour-Sensing model of hyphal growth. Mycol Res (2004) 1.03